• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gemini Therapeutics, Inc. - Common Stock (NQ:GMTX)

N/A UNCHANGED
Last Price Updated: 3:59 PM EST, Dec 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 1.090 (20)
Ask (Size) 1.330 (1)
Prev. Close 1.350
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 22,877,552
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation
February 21, 2023
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket ↗
December 28, 2022
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners. 
Via Benzinga

Performance

More News

Read More
News headline image
7 Short-Squeeze Stocks for Bold Contrarians to Consider ↗
November 21, 2022
Via InvestorPlace
News headline image
Gemini Therapeutics Announces Reverse Merger Pact With Hematology-Focused Company ↗
August 10, 2022
Via Benzinga
News headline image
GEMINI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. - GMTX
August 12, 2022
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
GMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Gemini Therapeutics, Inc. Is Fair to Shareholders
August 10, 2022
From Halper Sadeh LLP
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
August 10, 2022
Via Benzinga
News headline image
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗
August 10, 2022
Via Benzinga
News headline image
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗
August 11, 2022
Via Benzinga
News headline image
Gemini Therapeutics and Disc Medicine Announce Merger Agreement
August 10, 2022
From Gemini Therapeutics, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More ↗
April 14, 2022
Via Benzinga
News headline image
10 Biggest Price Target Changes For Friday ↗
March 11, 2022
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022 ↗
March 11, 2022
Via Benzinga
News headline image
What 5 Analyst Ratings Have To Say About Gemini Therapeutics ↗
March 03, 2022
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022 ↗
March 03, 2022
Via Benzinga
News headline image
10 Biggest Price Target Changes For Thursday ↗
March 03, 2022
Via Benzinga
News headline image
Read Why Did Jefferies Downgrade Gemini Therapeutics To Hold ↗
March 01, 2022
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
March 01, 2022
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022 ↗
March 01, 2022
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
March 01, 2022
Via Benzinga
News headline image
Gemini Therapeutics Provides Corporate Update
February 28, 2022
From Gemini Therapeutics, Inc.
Via Business Wire
News headline image
Gemini Therapeutics Provides GEM103 Program Update
January 10, 2022
From Gemini Therapeutics, Inc.
Via Business Wire
News headline image
46 Biggest Movers From Yesterday ↗
December 16, 2021
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Surges Over 100 Points After Federal Reserve's Policy Update ↗
December 15, 2021
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
December 15, 2021
Via Benzinga

Frequently Asked Questions

Is Gemini Therapeutics, Inc. - Common Stock publicly traded?
Yes, Gemini Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Gemini Therapeutics, Inc. - Common Stock trade on?
Gemini Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Gemini Therapeutics, Inc. - Common Stock?
The ticker symbol for Gemini Therapeutics, Inc. - Common Stock is GMTX on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap